MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Mitochondrial dysfunction"

  • 2026 International Congress

    Activation of the MT1 Receptor Ameliorates Mitochondrial Dysfunction in MPP+/MPTP-Induced Parkinson’s Disease

    LL. Qi, CF. Liu, F. Wang (Suzhou, China)

    Objective: This study aimed to explore the role of melatonin receptor 1 (MT1) in improving mitochondrial dysfunction in MPP⁺/MPTP-induced PD models and to clarify the…
  • 2026 International Congress

    Midbrain Organoid Modeling and Transcriptomic Characterization of NOTCH2NLC GGC Repeat Expansion–Associated Parkinson’s Disease

    H. Qian, Y. Chen, W. Wei (Hangzhou, China)

    Objective: To characterize transcriptomic alterations in patient-derived midbrain organoids carrying NOTCH2NLC GGC repeat expansions and assess their relevance to canonical Parkinson's disease (PD) mechanisms. Background:…
  • 2026 International Congress

    Adolescent-onset Myoclonus Dystonia in MT-ND6 m.14487T>C–Associated Leigh Syndrome

    Y. Nishonova, S. Shokirov, I. Mazunin, O. Turgunkhujaev (Tashkent, Uzbekistan)

    Objective: To describe the clinical and genetic features of an adolescent patient with MT-ND6-associated Leigh syndrome presenting with a prominent dystonia and myoclonus. Background: Leigh…
  • 2026 International Congress

    Mitochondrial Density Shapes Regional Vulnerability to Atrophy in Parkinson’s Disease

    A. Konuri, L. Churchill, J. Anderson, A. Ignatavicius, G. Halliday, R. Landin-Romero, S. Lewis, E. Matar (Sydney, Australia)

    Objective: To characterise the coupling between regional mitochondrial density and complex I activity and spatially patterned brain atrophy in Parkinson's disease (PD), and its variation…
  • 2026 International Congress

    Targeting c-Abl/Drp1-Dependent Mitochondrial Fission: Neuroprotective Effects of Berberine Chloride in Parkinson’s Disease Models

    D. Khatri (Chandwaji, Jaipur, India)

    Objective: To investigate the neuroprotective potential of berberine chloride in Parkinson’s disease (PD) by modulating pathological mitochondrial fission through c-Abl–mediated Drp1 phosphorylation using integrated bioinformatics,…
  • 2026 International Congress

    Association of MT-ATP6 Polymorphisms with Increased Reactive Oxygen Species and Biomarker Alterations in Parkinson’s Disease

    B. Chandar, HSB. Suresh Babu, NR. Raj, MB. Balachandar, VL. Lakhanpal (Bathinda, India)

    Objective: To evaluate the association between MT-ATP6 gene polymorphisms, oxidative stress, and biomarker alterations in PD patients from Indian populaiton Background: Mitochondrial dysfunction and oxidative…
  • 2026 International Congress

    SNCA Dysregulation Drives Oxidative Stress and Mitochondrial Dysfunction in Parkinson’s Disease: Evidence from a Punjab Cohort

    MI. Iyer, HWS. Suresh Babu, SM. Muthukumar, VK. Lakhanpal, MKY. Yadav, BV. Vellingiri (Bathinda, India)

    Objective: This study aimed to investigate SNCA gene alterations alongside oxidative stress and mitochondrial dysfunction in early-onset PD (EOPD) and late-onset PD (LOPD) subjects from the Punjab…
  • 2026 International Congress

    Translational Target Engagement of HER-096 Demonstrates Concordant Proteostasis and Mitochondrial Modulation in Preclinical Models and Patients with Parkinson’s Disease

    K. Holmström, A. Ludwig, N. Kulesskaya, A. Domanska, K. Jääskeläinen, C. Videbaek, H. Huttunen (Espoo, Finland)

    Objective: To evaluate translational target engagement of HER-096, a CDNF-derived peptidomimetic, in preclinical models of Parkinson’s disease (PD) and in a Phase 1b clinical study…
  • 2026 International Congress

    PPAR-γ-dependent Neuroprotection by Ferulic acid improves Motor deficits in 3-nitropropionic acid model of Huntington’s disease in rats

    N. Singh, V. Singh (bathinda, India)

    Objective: This study investigates the neuroprotective role of FA in  3-nitropropionic acid (3-NP) model of HD through PPAR-γ–mediated mechanisms. Background: Huntington disease (HD) is a…
  • 2026 International Congress

    Investigating Mitochondrial Integrity in Spinocerebellar Ataxia Type 12 via Patient-Derived iPSC Models

    J. Rungta, R. Banerjee, S. Sengupta, B. Reddy, S. Ansari, R. Khatun, J. Ganguly, D. Dutta, S. Mukherjee, P. Basu, S. Choudhury, R. Pal, S. Chattarji, H. Kumar (Kolkata, India)

    Objective: This study aims to establish patient-derived induced pluripotent stem cell (iPSC) models of Spinocerebellar Ataxia Type 12 (SCA12) and investigate mitochondrial transcriptional alterations across…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley